AgomAb Therapeutics N.V. American Depositary Shares P/E Ratio

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) currently reports a P/E ratio of -10.2. That is below the Healthcare sector average of 26.36. Use the charts on this page to explore AgomAb Therapeutics N.V. American Depositary Shares's P/E ratio history and peer comparisons.

AgomAb Therapeutics N.V. American Depositary Shares's P/E ratio of -10.2 is lower than the Healthcare sector average of 26.36. That is roughly 138.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates AgomAb Therapeutics N.V. American Depositary Shares's market price to a fundamental measure such as earnings, sales, or book value. At -10.2, AGMB can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -10.2, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 26.36. From there, open related valuation or income-statement pages for AgomAb Therapeutics N.V. American Depositary Shares, and consider following AGMB for alerts when major investors trade the stock.

AgomAb Therapeutics N.V. American Depositary Shares is classified in the Healthcare sector. On P/E ratio, it currently shows -10.2 versus a sector average near 26.36. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGMB with unrelated industries.